Jeffrey Garro
Stock Analyst at Stephens
(0.07)
# 4,674
Out of 4,703 analysts
73
Total ratings
31.3%
Success rate
-23.3%
Average return
Main Sectors:
Stocks Rated by Jeffrey Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPRX OptimizeRx | Rated: Hold | $10 → $7 | $7.87 | -11.05% | 6 | May 13, 2026 | |
| HCAT Health Catalyst | Maintained: Hold | $2 → $1.75 | $1.69 | +3.55% | 5 | May 12, 2026 | |
| CERT Certara | Maintained: Buy | $12 → $9 | $7.94 | +13.35% | 6 | May 12, 2026 | |
| PHR Phreesia | Maintained: Buy | $37 → $20 | $10.94 | +82.82% | 3 | Mar 31, 2026 | |
| DH Definitive Healthcare | Maintained: Hold | $5 → $3 | $1.05 | +185.71% | 2 | Feb 27, 2026 | |
| EVH Evolent Health | Maintained: Buy | $7 | $4.32 | +62.04% | 4 | Feb 25, 2026 | |
| SLP Simulations Plus | Maintained: Buy | $28 → $20 | $18.43 | n/a | 3 | Jul 15, 2025 | |
| TDOC Teladoc Health | Maintained: Hold | $8 | $6.28 | n/a | 1 | Apr 30, 2025 | |
| PRVA Privia Health Group | Maintained: Buy | $26 → $30 | $20.66 | n/a | 3 | Mar 5, 2025 | |
| MDRX Veradigm Inc. | Maintained: Hold | $13 → $7 | $4.81 | n/a | 9 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $255 → $250 | $267.77 | n/a | 3 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $280 | $275.09 | n/a | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $55 | $26.35 | n/a | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $20 | $13.54 | n/a | 5 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $5 → $3.9 | $10.75 | n/a | 8 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $3 | $0.5362 | n/a | 7 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $158.78 | n/a | 1 | Dec 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | - | n/a | 5 | May 6, 2020 |
OptimizeRx
May 13, 2026
Rated: Hold
Price Target: $10 → $7
Current: $7.87
Upside: -11.05%
Health Catalyst
May 12, 2026
Maintained: Hold
Price Target: $2 → $1.75
Current: $1.69
Upside: +3.55%
Certara
May 12, 2026
Maintained: Buy
Price Target: $12 → $9
Current: $7.94
Upside: +13.35%
Phreesia
Mar 31, 2026
Maintained: Buy
Price Target: $37 → $20
Current: $10.94
Upside: +82.82%
Definitive Healthcare
Feb 27, 2026
Maintained: Hold
Price Target: $5 → $3
Current: $1.05
Upside: +185.71%
Evolent Health
Feb 25, 2026
Maintained: Buy
Price Target: $7
Current: $4.32
Upside: +62.04%
Simulations Plus
Jul 15, 2025
Maintained: Buy
Price Target: $28 → $20
Current: $18.43
Upside: n/a
Teladoc Health
Apr 30, 2025
Maintained: Hold
Price Target: $8
Current: $6.28
Upside: n/a
Privia Health Group
Mar 5, 2025
Maintained: Buy
Price Target: $26 → $30
Current: $20.66
Upside: n/a
Veradigm Inc.
Jan 31, 2025
Maintained: Hold
Price Target: $13 → $7
Current: $4.81
Upside: n/a
Dec 19, 2024
Initiated Coverage: Buy
Price Target: $255 → $250
Current: $267.77
Upside: n/a
Dec 19, 2024
Initiated Coverage: Buy
Price Target: $280
Current: $275.09
Upside: n/a
Dec 19, 2024
Initiated Coverage: Hold
Price Target: $55
Current: $26.35
Upside: n/a
Aug 5, 2022
Maintained: Buy
Price Target: $15 → $20
Current: $13.54
Upside: n/a
May 11, 2022
Maintained: Sell
Price Target: $5 → $3.9
Current: $10.75
Upside: n/a
May 5, 2022
Maintained: Hold
Price Target: $4 → $3
Current: $0.5362
Upside: n/a
Dec 20, 2021
Maintained: Buy
Price Target: n/a
Current: $158.78
Upside: n/a
May 6, 2020
Reiterated: Hold
Price Target: n/a
Current: -
Upside: n/a